C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 403/12 (2006.01) A61K 31/4025 (2006.01) A61P 11/00 (2006.01) C07D 413/12 (2006.01)
Patent
CA 2589744
Compounds of formula (I) in salt or zwitterionic form, wherein R1, R2, R3, R4 and R5 have the meanings as indicated in the specification, are useful for treating conditions that are mediated by the muscarinic M3 receptor. Pharmaceutical compositions that contain the compounds and a process for preparing the compounds are also described.
L'invention concerne des composés représentés par la formule (I), sous forme de sel ou de zwitterion, dans laquelle R1, R2, R3, R4 et R5 sont tels que définis dans les spécifications. Ces composés sont utiles pour traiter des états pathologiques à médiation par le récepteur M3 muscarinique. L'invention concerne également des compositions pharmaceutiques contenant ces composés ainsi qu'un procédé de préparation de ces composés.
Collingwood Stephen Paul
Press Neil John
Fetherstonhaugh & Co.
Novartis Ag
LandOfFree
Pyrrolinidium derivatives as m3 muscarinic receptors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrrolinidium derivatives as m3 muscarinic receptors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrrolinidium derivatives as m3 muscarinic receptors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1567425